Cannabis Patient Human Rights Statement
The right to health is a fundamental right of the human being. The fact that the State criminalizes sick people for using substances that improve their health is an attack on public health. At present, no minimally informed scientific establishment would dare to deny the therapeutic benefits of the cannabis plant , and those that do, or have economic benefits to take from this position or are, purely and simply, have a lack of knowledge that Border the immoral.
The International Association for Cannabinoid Medicines (IACM) is working to publicize this movement that revolves around the Declaration of Human Rights of Cannabis Patients. According to the Universal Declaration of Human Rights of 1948, every individual “has the right to life, liberty and security of person” (article 3) and “has the right to an adequate standard of living to ensure, as well as Their families, their health and well-being, especially food, clothing, housing, medical care and social services “(art. 25, para. 1).
Considering that this statement applies to all persons and peoples, that many doctors are prohibited by law from treating their patients with cannabis-derived medicines and that many people do not have access to cannabis-derived drugs, we declare that:
All doctors have the right to treat their patients with cannabis derivatives.
All patients have the right to access to cannabis derivatives as treatment supervised by a physician, regardless of their social status, standard of living or economic environment.
If the cannabis medicines currently on the market had a wide range of indications, the use of these drugs could be justified to the detriment of cannabis in its vegetable form. But the truth is that this is not so. And this is not so, not because these indications are not scientifically proven for cannabis, but because, for a drug to obtain authorization to be used for indications other than the first for which it was marketed, it must present a sufficient number Well-designed scientific studies and reproducible results when that particular drug is used.
The Sativex, which is called the cannabinoid spray, whose only formal indication is spasticity and ataxia resistant to other treatments in multiple sclerosis, will take many, but many years, to obtain the necessary authorizations by the authorities Competent to be used in the rest of the medical indications in which cannabinoids have been shown to work. The next indication on the horizon is cancer pain.